Akso Health Group annual ebitda
2016
2017
2018
2019
2020
2021
2022
2025
2026
Akso Health Group EBITDA Growth & History (AHG)
Akso Health Group's calculated EBITDA was −$18.3M for fiscal 2026.
View full Akso Health Group company overviewAkso Health Group annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | −$18.3M | $145.8M | — |
| 2025 | 2025-03-31 | −$164.2M | −$160.9M | — |
| 2022 | 2022-03-31 | −$3.2M | $984,015 | — |
| 2021 | 2021-03-31 | −$4.2M | $43.8M | — |
| 2020 | 2020-03-31 | −$48.0M | −$40.8M | — |
| 2019 | 2019-03-31 | −$7.2M | −$83.2M | — |
| 2018 | 2018-03-31 | $76.0M | $66.0M | +660.06% |
| 2017 | 2017-03-31 | $10.0M | $5.8M | +138.13% |
| 2016 | 2016-03-31 | $4.2M | — | — |
Akso Health Group quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Akso Health Group ebitda trends
Over the last five reported fiscal years, Akso Health Group's ebitda decreased from −$7.2M to −$18.3M, a change of −$11.2M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Akso Health Group filings at SEC.gov ↗